Related content

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

By Beer T.M.   Eilers K.M.   Garzotto M.   Egorin M.J.   Lowe B.A.   Henner W.D.   Hsieh J.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 314-315

Elsevier

Access to resources Recommend Favorite

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

By Zelefsky M.J.   Fuks Z.   Hunt M.   Yamada Y.   Marion C.   Ling C.C.   Amols H.   Venkatraman E.S.   Leibel S.A.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 306-307

Elsevier

Access to resources Recommend Favorite

FEC Mobilized Stem Cells for High-dose Therapy in Breast Cancer Patients

By Lindman Henrik   Wiklund Tom   Holte Harald   Ljungman Per   Blomqvist Carl   Kvalheim Gunnar   Bengtsson Mats   Höglund Martin   Wilking Nils   Bergh Jonas  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 239-245

Informa Healthcare

Access to resources Recommend Favorite

A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer

By Hamilton Michael   Dahut William   Brawley Otis   Davis Patricia   Wells-jones Toni   Kohler David   Duray Paul   Liewehr David J.   Lakhani Nehal   Steinberg Seth M.   Figg William D.   Reed Eddie  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 195-201

Informa Healthcare

Access to resources Recommend Favorite

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

By Schick Ulrike   Jorcano Sandra   Nouet Philippe   Rouzaud Michel   Vees Hansjoerg   Zilli Thomas   Ratib Osman   Weber Damien C.   Miralbell Raymond  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1622-1628

Informa Healthcare

Access to resources Recommend Favorite